BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19524867)

  • 1. Relaxin and its role in the development and treatment of fibrosis.
    Bennett RG
    Transl Res; 2009 Jul; 154(1):1-6. PubMed ID: 19524867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease.
    McGuane JT; Parry LJ
    Expert Rev Mol Med; 2005 Sep; 7(21):1-18. PubMed ID: 16191259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease.
    Samuel CS; Lekgabe ED; Mookerjee I
    Adv Exp Med Biol; 2007; 612():88-103. PubMed ID: 18161483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin and the progression of kidney disease.
    Samuel CS; Hewitson TD
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):9-14. PubMed ID: 19077683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin's physiological roles and other diverse actions.
    Sherwood OD
    Endocr Rev; 2004 Apr; 25(2):205-34. PubMed ID: 15082520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.
    Nistri S; Bigazzi M; Bani D
    Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):101-8. PubMed ID: 17430134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
    Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
    FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.
    Marshall SA; Senadheera SN; Parry LJ; Girling JE
    Reprod Sci; 2017 Mar; 24(3):342-354. PubMed ID: 27365367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of relaxin in regulation of fibrosis in the lung.
    Tang ML; Samuel CS; Royce SG
    Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
    Garber SL; Mirochnik Y; Brecklin CS; Unemori EN; Singh AK; Slobodskoy L; Grove BH; Arruda JA; Dunea G
    Kidney Int; 2001 Mar; 59(3):876-82. PubMed ID: 11231342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin physiology in the female reproductive tract during pregnancy.
    Parry LJ; Vodstrcil LA
    Adv Exp Med Biol; 2007; 612():34-48. PubMed ID: 18161480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin: an endogenous renoprotective factor?
    Hewitson TD; Samuel CS
    Ann N Y Acad Sci; 2009 Apr; 1160():289-93. PubMed ID: 19416206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease.
    Samuel CS; Royce SG; Chen B; Cao H; Gossen JA; Tregear GW; Tang ML
    Endocrinology; 2009 Mar; 150(3):1495-502. PubMed ID: 18974264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing relaxin receptor expression and exploring relaxin's effect on tissue remodeling/fibrosis in the human bladder.
    Diaz EC; Briggs M; Wen Y; Zhuang G; Wallace SL; Dobberfuhl AD; Kao CS; Chen BC
    BMC Urol; 2020 Apr; 20(1):44. PubMed ID: 32321501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin in cardiovascular and renal disease.
    Samuel CS; Hewitson TD
    Kidney Int; 2006 May; 69(9):1498-502. PubMed ID: 16672919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system.
    Jelinic M; Marshall SA; Leo CH; Parry LJ; Tare M
    Microcirculation; 2019 Feb; 26(2):e12464. PubMed ID: 29876993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-fibrotic actions of relaxin.
    Samuel CS; Royce SG; Hewitson TD; Denton KM; Cooney TE; Bennett RG
    Br J Pharmacol; 2017 May; 174(10):962-976. PubMed ID: 27250825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective actions of relaxin.
    Martin B; Romero G; Salama G
    Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mast cell in fibrosis.
    Rothe MJ; Kerdel FA
    Int J Dermatol; 1991 Jan; 30(1):13-6. PubMed ID: 1993559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.